Raras
Buscar doenças, sintomas, genes...
Cegueira noturna estacionária congênita
ORPHA:215CID-10 · H53.6CID-11 · 9D45DOENÇA RARA

O receptor metabotrópico de glutamato 6 é uma proteína que em seres humanos é codificada pelo gene GRM6. Os receptores metabotrópicos de glutamato são uma família de receptores acoplados à proteína G.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Cegueira noturna estacionária congênita é uma condição genética rara que causa dificuldade de enxergar em ambientes com pouca luz desde o nascimento. Pode apresentar visão reduzida, estrabismo, alterações na pigmentação da retina e defeitos na visão de cores, com herança autossômica ou ligada ao X.

Pesquisas ativas
1 ensaio
3 total registrados no ClinicalTrials.gov
Publicações científicas
632 artigos
Último publicado: 2026 Apr 9

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +10CID-10: H53.6
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
30 sintomas
🧬
Pele e cabelo
2 sintomas
💪
Músculos
1 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

90%prev.
Acuidade visual reduzida
Muito frequente (99-80%)
90%prev.
Miopia
Muito frequente (99-80%)
90%prev.
Nictalopia
Muito frequente (99-80%)
90%prev.
Eletroretinograma anormal adaptado ao escuro
Muito frequente (99-80%)
55%prev.
Estrabismo
Frequente (79-30%)
55%prev.
Cegueira noturna estacionária congênita com fundo de olho anormal
45sintomas
Muito frequente (4)
Frequente (5)
Ocasional (4)
Muito raro (3)
Sem dados (29)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 45 características clínicas mais associadas, ordenadas por frequência.

Acuidade visual reduzidaReduced visual acuity
Muito frequente (99-80%)90%
MiopiaMyopia
Muito frequente (99-80%)90%
NictalopiaNyctalopia
Muito frequente (99-80%)90%
Eletroretinograma anormal adaptado ao escuroAbnormal dark-adapted electroretinogram
Muito frequente (99-80%)90%
EstrabismoStrabismus
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico632PubMed
Últimos 10 anos200publicações
Pico202533 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

15 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

GPR179Probable G-protein coupled receptor 179Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Orphan receptor involved in vision (PubMed:22325362, PubMed:24084093). Required for signal transduction through retinal depolarizing bipolar cells (PubMed:22325362). Acts as an atypical G-protein coupled receptor that recruits and regulates the R7 group RGS-GNB5 complexes instead of activating G proteins: promotes the GTPase activator activity of R7 RGS proteins, increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (By similarity). A

LOCALIZAÇÃO

Cell membranePostsynaptic cell membraneCell projection, dendrite

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1E

An autosomal recessive, non-progressive retinal disorder characterized by impaired night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. Affected individuals have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cérebro - Hemisfério cerebelar
2.5 TPM
Cerebelo
2.5 TPM
Córtex cerebral
1.5 TPM
Brain Frontal Cortex BA9
1.4 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1E
HGNC:31371UniProt:Q6PRD1
PDE6BRod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Rod-specific cGMP phosphodiesterase that catalyzes the hydrolysis of 3',5'-cyclic GMP (PubMed:20940301). Necessary for the formation of a functional phosphodiesterase holoenzyme (By similarity). Involved in retinal circadian rhythm photoentrainment via modulation of UVA and orange light-induced phase-shift of the retina clock (By similarity). May participate in processes of transmission and amplification of the visual signal (PubMed:8394174)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 40

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
22.1 TPM
Hipocampo
14.7 TPM
Brain Caudate basal ganglia
14.3 TPM
Brain Nucleus accumbens basal ganglia
13.9 TPM
Substância negra
13.4 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 40congenital stationary night blindness autosomal dominant 2retinitis pigmentosa
HGNC:8786UniProt:P35913
CABP4Calcium-binding protein 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in normal synaptic function through regulation of Ca(2+) influx and neurotransmitter release in photoreceptor synaptic terminals and in auditory transmission. Modulator of CACNA1D and CACNA1F, suppressing the calcium-dependent inactivation and shifting the activation range to more hyperpolarized voltages (By similarity)

LOCALIZAÇÃO

CytoplasmPresynapse

MECANISMO DE DOENÇA

Cone-rod synaptic disorder, congenital non-progressive

A non-progressive retinal disorder characterized by stable low vision, nystagmus, photophobia, a normal or near-normal fundus appearance, and no night blindness.

OUTRAS DOENÇAS (2)
cone-rod synaptic disorder, congenital nonprogressiveautosomal dominant nocturnal frontal lobe epilepsy
HGNC:1386UniProt:P57796
GUCY2DRetinal guanylyl cyclase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors. Plays an essential role in phototransduction, by mediating cGMP replenishment (PubMed:15123990, PubMed:21928830, PubMed:26100624, PubMed:30319355, PubMed:9600905). May also participate in the trafficking of membrane-associated proteins to the photoreceptor outer segment membrane (By similarity)

LOCALIZAÇÃO

Photoreceptor outer segment membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Leber congenital amaurosis 1

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.5 TPM
Esôfago - Mucosa
0.7 TPM
Próstata
0.5 TPM
Vagina
0.3 TPM
Glândula salivar
0.3 TPM
OUTRAS DOENÇAS (8)
Leber congenital amaurosis 1night blindness, congenital stationary, type1ichoroidal dystrophy, central areolar, 1cone-rod dystrophy 6
HGNC:4689UniProt:Q02846
TRPM1Transient receptor potential cation channel subfamily M member 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Constitutively open nonselective divalent cation-conducting channels which mediate the influx of Ca(2+), Mg(2+), Mn(2+), Ba(2+), and Ni(2+) into the cytoplasm, leading to membrane depolarization (PubMed:11535825, PubMed:19436059, PubMed:21278253). Impermeable to zinc ions (PubMed:21278253). In addition, forms heteromultimeric ion channels with TRPM3 which are permeable for calcium and zinc ions (PubMed:21278253). Plays an essential role for the depolarizing photoresponse of retinal ON bipolar ce

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneCell projection, axon

VIAS BIOLÓGICAS (2)
TRP channelsRegulation of MITF-M-dependent genes involved in apoptosis
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1C

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Skin Sun Exposed Lower leg
3.3 TPM
Skin Not Sun Exposed Suprapubic
3.1 TPM
Testículo
2.8 TPM
Brain Spinal cord cervical c-1
0.7 TPM
Substância negra
0.5 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1C
HGNC:7146UniProt:Q7Z4N2
GNAT1Guanine nucleotide-binding protein G(t) subunit alpha-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as a signal transducer for the rod photoreceptor RHO. Required for normal RHO-mediated light perception by the retina (PubMed:22190596). Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs), such as the photoreceptor RHO. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Activated RHO promotes GDP release and GTP binding. S

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembranePhotoreceptor inner segment

MECANISMO DE DOENÇA

Night blindness, congenital stationary, autosomal dominant 3

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.2 TPM
Fígado
0.1 TPM
Brain Spinal cord cervical c-1
0.1 TPM
Pituitária
0.1 TPM
Córtex cerebral
0.1 TPM
OUTRAS DOENÇAS (2)
congenital stationary night blindness 1Gcongenital stationary night blindness autosomal dominant 3
HGNC:4393UniProt:P11488
NYXNyctalopinDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Required for normal vision. Is a critical factor for light-induced depolarization of retinal ON-bipolar cells, likely acting as a scaffold for TRPM1 and GRM6. Required for TRPM1 trafficking to dendritic tips of ON-bipolar cells

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixCell projection, dendritePostsynapse

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1A

A non-progressive retinal disorder characterized by impaired night vision. Congenital stationary night blindness type 1A is characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.6 TPM
Rim - Córtex
0.2 TPM
Rim - Medula
0.1 TPM
Linfócitos
0.1 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1A
HGNC:HGNC:8082UniProt:Q9GZU5
GRM6Metabotropic glutamate receptor 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity (By similarity). Signaling stimulates TRPM1 channel activity and Ca(2+) uptake. Required for normal vision

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneGolgi apparatus membraneCell projection, dendrite

VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsClass C/3 (Metabotropic glutamate/pheromone receptors)
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1B

A non-progressive retinal disorder characterized by impaired night vision. Congenital stationary night blindness type 1B is an autosomal recessive form associated with a negative electroretinogram waveform. Patients are night blind from an early age, and when maximally dark-adapted, they could perceive lights only with an intensity equal to or slightly dimmer than that normally detected by the cone system. ERGs in response to single brief flashes of light have clearly detectable a-waves, which are derived from photoreceptors, and greatly reduced b-waves, which are derived from the second-order inner retinal neurons. ERGs in response to sawtooth flickering light indicate a markedly reduced on response and a nearly normal OFF response. There is no subjective delay in the perception of suddenly appearing white vs black objects on a gray background.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.9 TPM
Pituitária
1.5 TPM
Cerebelo
1.0 TPM
Cérebro - Hemisfério cerebelar
1.0 TPM
Próstata
0.8 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1B
HGNC:4598UniProt:O15303
GRK1Rhodopsin kinase GRK1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Retina-specific kinase involved in the signal turnoff via phosphorylation of rhodopsin (RHO), the G protein- coupled receptor that initiates the phototransduction cascade (PubMed:15946941). This rapid desensitization is essential for scotopic vision and permits rapid adaptation to changes in illumination (By similarity). May play a role in the maintenance of the outer nuclear layer in the retina (By similarity)

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 2

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.2 TPM
Testículo
0.6 TPM
Pituitária
0.2 TPM
Cerebelo
0.1 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
OUTRAS DOENÇAS (2)
Oguchi disease-2Oguchi disease
HGNC:10013UniProt:Q15835
SAGS-arrestinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO (By similarity). May play a role in preventing light-dependent degeneration of retinal photoreceptor cells (PubMed:9565049)

LOCALIZAÇÃO

Cell projection, cilium, photoreceptor outer segmentMembrane

VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 1

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
7.2 TPM
Brain Nucleus accumbens basal ganglia
4.1 TPM
Brain Caudate basal ganglia
1.2 TPM
Brain Putamen basal ganglia
0.7 TPM
Cervix Endocervix
0.4 TPM
OUTRAS DOENÇAS (5)
Oguchi disease-1retinitis pigmentosa 47retinitis pigmentosa 96retinitis pigmentosa
HGNC:10521UniProt:P10523
RHORhodopsinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Photoreceptor required for image-forming vision at low light intensity (PubMed:7846071, PubMed:8107847). Required for photoreceptor cell viability after birth (PubMed:12566452, PubMed:2215617). Light-induced isomerization of the chromophore 11-cis-retinal to all-trans-retinal triggers a conformational change that activates signaling via G-proteins (PubMed:26200343, PubMed:28524165, PubMed:28753425, PubMed:8107847). Subsequent receptor phosphorylation mediates displacement of the bound G-protein

LOCALIZAÇÃO

MembraneCell projection, cilium, photoreceptor outer segment

VIAS BIOLÓGICAS (4)
OpsinsG alpha (i) signalling eventsThe canonical retinoid cycle in rods (twilight vision)Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 4

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
0.5 TPM
Cerebelo
0.5 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Córtex cerebral
0.5 TPM
Testículo
0.2 TPM
OUTRAS DOENÇAS (6)
retinitis pigmentosa 4fundus albipunctatuscongenital stationary night blindness autosomal dominant 1retinitis pigmentosa
HGNC:10012UniProt:P08100
LRIT3Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the synapse formation and synaptic transmission between cone photoreceptor cells and retinal bipolar cells (By similarity). Required for normal transmission of a light-evoked stimulus from the cone photoreceptor cells to the ON-bipolar cells and ON-ganglion cells in the inner retina (PubMed:28334377). Required in retinal ON-bipolar cells for normal localization of the cation channel TRPM1 at dendrite tips (By similarity). Seems to play a specific role in synaptic contacts made by

LOCALIZAÇÃO

Cell projection, dendritePerikaryonEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1F

An autosomal recessive form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
1.7 TPM
Cérebro - Hemisfério cerebelar
1.7 TPM
Nervo tibial
1.5 TPM
Testículo
1.2 TPM
Cervix Endocervix
1.0 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1F
HGNC:24783UniProt:Q3SXY7
GNB3Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction

LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
Extra-nuclear estrogen signalingGPER1 signalingThromboxane signalling through TP receptorADORA2B mediated anti-inflammatory cytokines productionProstacyclin signalling through prostacyclin receptor
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1H

A form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision or in dim light, with good vision only on bright days. CSNB1H patients present with childhood-onset night blindness and middle age-onset photophobia, but have near-normal vision and do not exhibit nystagmus or high myopia. CSNB1H inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
84.8 TPM
Cerebelo
62.6 TPM
Cérebro - Hemisfério cerebelar
49.2 TPM
Ovário
19.4 TPM
Útero
18.7 TPM
OUTRAS DOENÇAS (2)
congenital stationary night blindness 1Hessential hypertension, genetic
HGNC:HGNC:4400UniProt:P16520
CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkyla

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Night blindness, congenital stationary, 2A

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

OUTRAS DOENÇAS (4)
congenital stationary night blindness 2AX-linked cone-rod dystrophy 3Aland island eye diseasecone-rod dystrophy
HGNC:1393UniProt:O60840
SLC24A1Sodium/potassium/calcium exchanger 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium, potassium:sodium antiporter that transports 1 Ca(2+) and 1 K(+) in exchange for 4 Na(+) (PubMed:26631410). Critical component of the visual transduction cascade, controlling the calcium concentration of outer segments during light and darkness (PubMed:20850105). Light causes a rapid lowering of cytosolic free calcium in the outer segment of both retinal rod and cone photoreceptors and the light-induced lowering of calcium is caused by extrusion via this protein which plays a key role in

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Sodium/Calcium exchangersActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1D

An autosomal recessive form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision. CSNB1D is characterized by a Riggs type of electroretinogram (proportionally reduced a- and b-waves). Patients have visual acuity within the normal range and no symptoms of myopia and/or nystagmus.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
9.4 TPM
Testículo
8.3 TPM
Tireoide
7.3 TPM
Ovário
6.6 TPM
Útero
6.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1D
HGNC:HGNC:10975UniProt:O60721

Variantes genéticas (ClinVar)

513 variantes patogênicas registradas no ClinVar.

🧬 GPR179: GRCh37/hg19 17q12-21.2(chr17:33220181-39572233)x3 ()
🧬 GPR179: NM_001004334.4(GPR179):c.3238C>T (p.Gln1080Ter) ()
🧬 GPR179: NM_001004334.4(GPR179):c.1874dup (p.Ile626fs) ()
🧬 GPR179: NM_001004334.4(GPR179):c.268_269delinsTA (p.Gly90Ter) ()
🧬 GPR179: NM_001004334.4(GPR179):c.955T>C (p.Cys319Arg) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,072 variantes classificadas pelo ClinVar.

429
643
Patogênica (40.0%)
VUS (60.0%)
VARIANTES MAIS SIGNIFICATIVAS
CACNA1F: NM_001256789.3(CACNA1F):c.1438del (p.Ala480fs) [Pathogenic/Likely pathogenic]
NYX: NM_001378477.3(NYX):c.1108dup (p.Gln370fs) [Pathogenic]
CACNA1F: NM_001256789.3(CACNA1F):c.3793-2A>T [Likely pathogenic]
SLC24A1: NM_004727.3(SLC24A1):c.2015dup (p.Tyr672Ter) [Likely pathogenic]
CACNA1F: NM_001256789.3(CACNA1F):c.1208dup (p.Tyr404fs) [Likely pathogenic]

Vias biológicas (Reactome)

40 vias biológicas associadas aos genes desta condição.

Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade Ca2+ pathway TRP channels Regulation of MITF-M-dependent genes involved in apoptosis G alpha (i) signalling events Class C/3 (Metabotropic glutamate/pheromone receptors) The canonical retinoid cycle in rods (twilight vision) Opsins VxPx cargo-targeting to cilium Activation of G protein gated Potassium channels Glucagon signaling in metabolic regulation G-protein activation Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) ADP signalling through P2Y purinoceptor 12 G beta:gamma signalling through PI3Kgamma Prostacyclin signalling through prostacyclin receptor Adrenaline,noradrenaline inhibits insulin secretion G alpha (q) signalling events G alpha (12/13) signalling events G beta:gamma signalling through PLC beta G alpha (s) signalling events ADP signalling through P2Y purinoceptor 1 G alpha (z) signalling events Glucagon-type ligand receptors Thromboxane signalling through TP receptor Vasopressin regulates renal water homeostasis via Aquaporins Thrombin signalling through proteinase activated receptors (PARs) Presynaptic function of Kainate receptors Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding G beta:gamma signalling through BTK G beta:gamma signalling through CDC42 Extra-nuclear estrogen signaling GPER1 signaling ADORA2B mediated anti-inflammatory cytokines production Sensory perception of sweet, bitter, and umami (glutamate) taste High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Sodium/Calcium exchangers Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 3 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Cegueira noturna estacionária congênita

Centros de Referência SUS

24 centros habilitados pelo SUS para Cegueira noturna estacionária congênita

Centros para Cegueira noturna estacionária congênita

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

3 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
256 papers (10 anos)
#1

Cryo-EM structure of TRPM1 reveals a non-canonical architecture with an inverted transmembrane domain.

Nature communications2026 Mar 19

Transient receptor potential melastatin 1 (TRPM1) is a membrane protein essential for vision in dim light, and mutations in TRPM1 cause complete congenital stationary night blindness. Although TRPM1 shares sequence similarity to other TRPM ion channels such as TRPM3, whether it independently functions as an ion channel remains controversial. This controversy is largely caused by TRPM1's challenging biochemical behaviors that prevent detailed molecular characterization. In this work, we isolate TRPM1 and determine its structures using cryogenic electron microscopy (cryo-EM). The structures reveal a canonical tetrameric fold in the intracellular domain, consistent with other TRPM family members that are ion channels. Surprisingly, in the transmembrane domain, despite the presence of the conserved voltage sensor-like domain (VSLD) and pore domain (PD) in a domain-swapped fashion, the VSLD and PD are arranged with an opposite handedness compared to other related channels. This inverted transmembrane domain allows the formation of a large pore-like structure that supports the role of TRPM1 as an ion channel. This non-canonical architecture of TRPM1 may also confer unique permeation and pharmacological properties.

#2

CryoEM structure of mGlu6 captures receptor activation prior to G protein coupling.

Nature communications2026 Mar 09

The metabotropic glutamate receptor 6 (mGlu6) is essential for synaptic communication of rod photoreceptors, and mutations in mGlu6 lead to a blinding disorder. However, its structural organization remains unknown. Here, we present the structure of agonist-bound mGlu6, revealing an asymmetric dimer arrangement in the absence of a G protein. This indicates that agonist binding alone can induce the homodimeric receptor asymmetry in metabotropic glutamate receptors and structurally prime mGlu6 for activation by pre-organizing the transmembrane domain dimer interface for G protein binding. The structure also identifies noncanonical interactions between the cysteine-rich domain and extracellular loop 2, forming a unique interface that likely stabilizes the activation state. Mutational analyses of this interface reveal its role in maintaining rapid Gαo activation and surface targeting. The structure also permits mechanistic investigation of congenital stationary night blindness and reveals diverse effects of pathogenic mutations on surface trafficking, Gαo coupling, and activation dynamics, including unexpected gain-of-function. These results provide critical insight into the intermediate asymmetric structure of mGlu6 and offer a molecular framework for understanding the pathogenesis of inherited retinal disorders.

#3

EGFLAM Pathogenic Variants and Congenital Stationary Night Blindness.

JAMA ophthalmology2026 Jan 01

Congenital stationary night blindness (CSNB) is a clinically and genetically heterogeneous inherited retinal disorder (IRD), and in many complete CSNB (cCSNB) cases, the underlying genetic cause remains unknown. Uncovering the genetic defects of IRDs helps to refine diagnostic methods and supports the development of specific therapeutic approaches. To describe the phenotype and the underlying gene defect in patients with cCSNB from 2 unrelated families. This retrospective case series was conducted from January 2023 to July 2025. Data for 3 patients from cohorts of genetically unsolved IRD cases in France (n = 140 for CSNB) and the Netherlands (n = 2730 for IRD) were analyzed clinically and genetically. Complete ocular examination, including multimodal retinal imaging and full-field electroretinography (ffERG) incorporating the International Society for Clinical Electrophysiology of Vision standards and multimodal retinal imaging, were performed. Gene defects were identified by genome sequencing (GS) and exome sequencing (ES). The main outcome was a gene defect, EGFLAM, underlying cCSNB. Measures included phenotyping, GS, ES, Sanger sequencing, and cosegregation analysis. The series included 3 patients from 2 unrelated families of Moroccan ancestry showing high myopia, reduced visual acuity, and night blindness. Retinal imaging depicted myopic changes. ffERG revealed electronegative Schubert-Bornschein configuration in keeping with cCSNB with ON-bipolar cell dysfunction. Patients were lacking pathogenic variants in known genes implicated in IRDs, including CSNB. Two different homozygous pathogenic variants, c.1563_1566del, p.(Val522Glufs*18) and c.1795C>T, p.(Arg599*) in EGFLAM were identified by ES and GS. The corresponding protein is localized in the outer plexiform layer and important for ON-bipolar cell signaling in the retina. This case series reports on a gene defect in EGFLAM implicated in human cCSNB. Clinicians should be aware about this association and consider including EGFLAM in diagnostic gene panels for IRDs. This discovery may lead to faster and more accurate diagnosis of cCSNB and genetic counseling, as well as a pathway for developing therapies.

#4

A New Gene for Congenital Stationary Night Blindness.

JAMA ophthalmology2026 Jan 01
#5

G-protein activation of the dark-state conformation of the visual G protein-coupled receptor rhodopsin by releasing critical structural constraints.

Communications biology2026 Mar 03

G protein-coupled receptors (GPCRs) operate through the binding and activation of heterotrimeric G proteins. Ligand interaction drives the receptor's transition from an inactive to an active state, ultimately triggering G-protein activation and downstream signal transduction. The visual GPCR rhodopsin contains the chromophore 11-cis-retinal, which is covalently bound and functions as an inverse agonist, maintaining very low basal activity in the absence of light. Disruption of this basal receptor activity can lead to physiological consequences associated with retinal diseases such as congenital stationary night blindness and retinitis pigmentosa. Here, we describe a functional dark-state rhodopsin generated through engineered double and triple mutations at three well-defined structural microswitches that regulate the conformational stability of the dark ground-state: i) T942.61I, located near the protonated Schiff base linkage environment and linked to congenital stationary night blindness; ii) M2576.40Y positioned close to the tyrosine cluster (Y2235.58 and Y3067.53 of the NPxxY motif); and iii) E1343.49 within the conserved (D/E)RY motif, which participates in the so-called ionic lock involving R1353.50 and E2476.30. Characterization of these mutant rhodopsins provides additional insights into the structural basis of the inactive-to-active conformational transition in important functional domains and emphasizes rhodopsin conformational flexibility.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC295 artigos no totalmostrando 197

2026

Cryo-EM structure of TRPM1 reveals a non-canonical architecture with an inverted transmembrane domain.

Nature communications
2026

CryoEM structure of mGlu6 captures receptor activation prior to G protein coupling.

Nature communications
2026

G-protein activation of the dark-state conformation of the visual G protein-coupled receptor rhodopsin by releasing critical structural constraints.

Communications biology
2026

Identification and functional validation of a novel disease-causing variant in the noncoding region of NYX.

Acta ophthalmologica
2026

Are There Night Driving Restrictions for Patients with Incomplete Congenital Stationary Night Blindness?

Klinische Monatsblatter fur Augenheilkunde
2026

EGFLAM Pathogenic Variants and Congenital Stationary Night Blindness.

JAMA ophthalmology
2026

A New Gene for Congenital Stationary Night Blindness.

JAMA ophthalmology
2025

Genetic Spectrum of Negative Electroretinograms in a Predominantly Pediatric Cohort of 177 Patients.

Investigative ophthalmology &amp; visual science
2025

Pattern Electroretinography Signal Reconstruction in Rare Eye Diseases using Wavelet Transform.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
2025

Mild RPE65-Associated Inherited Retinal Dystrophies: A Multimodal Clinical and Genetic Evaluation.

Translational vision science &amp; technology
2025

Quantitative Proteomics Identifies Potential Molecular Adaptations in Mouse Models of Congenital Stationary Night Blindness Type 2.

Molecular &amp; cellular proteomics : MCP
2025

Incomplete congenital stationary night blindness associated with a novel variant in the CACNA1F gene.

Documenta ophthalmologica. Advances in ophthalmology
2026

Atypical presentation of Oguchi disease with severe cystoid macular edema and compound heterozygous SAG pathogenic variants.

Ophthalmic genetics
2025

A mechanism for pathological oscillations in mouse retinal ganglion cells in a model of night blindness.

The Journal of general physiology
2025

The physiology of dark adaptation: Progress and future directions.

Progress in retinal and eye research
2025

Domain-specific functions of LRIT3 in synaptic assembly and retinal signal transmission.

bioRxiv : the preprint server for biology
2025

Natural course of refractive errors in early onset inherited retinal diseases.

Eye (London, England)
2025

Novel Grm6 Variant in a no b-wave (nob) Mouse Model: Phenotype Characterization and Gene Therapy.

Investigative ophthalmology &amp; visual science
2025

A Practical Introduction to Wavelet Analysis in Electroretinography.

medRxiv : the preprint server for health sciences
2025

Gene augmentation therapy treats mature mice with complete congenital stationary night blindness (cCSNB), improving retinal function and visual acuity.

bioRxiv : the preprint server for biology
2025

Novel structural variant in CACNA1F causing congenital stationary night blindness identified with whole genome sequencing.

Ophthalmic genetics
2025

Whole exome sequencing reveals pathogenic variants in CNGA3, CACNA1F, and RPGRIP1 in consanguineous Pakistani families with diverse retinal phenotypes.

PloS one
2025

Congenital Stationary Night Blindness.

Advances in experimental medicine and biology
2025

Electronegative electroretinograms in two siblings with bradyopsia, an underdiagnosed pediatric inherited retinal disorder.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Trends and Disparities in the Incidence and Prevalence of Inherited Retinal Diseases in the United States.

American journal of ophthalmology
2025

Divergent mechanisms of neural adaptation and instability in the mammalian retina.

Current biology : CB
2025

Characterisation and prevalence of inherited retinal diseases in the Finnish population reveals enrichment of population-specific phenotypes and causative variants.

The British journal of ophthalmology
2025

Genetic analysis of congenital stationary night blindness and Oguchi disease in an Indian cohort.

Acta ophthalmologica
2025

Review of Four Refined Clinical Entities in Hereditary Retinal Disorders from Japan.

International journal of molecular sciences
2025

Dark Adaptometry as a Diagnostic Tool in Retinal Diseases: Mechanisms and Clinical Utility.

Journal of clinical medicine
2025

Understanding the phenotype of genetically associated electronegative ERG retinopathies: comparing the full-field ERG b:a ratio.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Ȧland Island eye disease in two patients harboring novel CACNA1F variants.

Ophthalmic genetics
2025

A New Phenotypic Expression in a Patient With a Mutation in the CACNA1F Gene.

Cureus
2025

Gene therapy shines light on congenital stationary night blindness for future cures.

Journal of translational medicine
2025

Genetic testing as a tool for diagnosis of congenital stationary night blindness (CSNB) in white spotted breeds in Poland.

Journal of equine veterinary science
2025

Congenital Stationary Night Blindness (CSNB)-Case Reports and Review of Current Knowledge.

Journal of clinical medicine
2025

The negative off-response driven by M-cone and depolarizing bipolar cell in the rat electroretinogram.

Scientific reports
2025

Defective glycosylation and ELFN1 binding of mGluR6 congenital stationary night blindness mutants.

Life science alliance
2025

Novel CACNA1F pathogenic variant in pediatric incomplete X-linked CSNB: integrating portable ERG and genetic analysis.

Documenta ophthalmologica. Advances in ophthalmology
2024

Natural Course of Refractive Error in Congenital Stationary Night Blindness: Implications for Myopia Treatment.

Investigative ophthalmology &amp; visual science
2024

Infantile Nystagmus Syndrome-Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials.

Life (Basel, Switzerland)
2024

Optic Neuropathy AFG3L2 Related in a Patient Affected by Congenital Stationary Night Blindness.

Case reports in ophthalmological medicine
2024

A non-conducting role of the Cav1.4 Ca2+ channel drives homeostatic plasticity at the cone photoreceptor synapse.

eLife
2024

Cryo-EM structure of human class C orphan GPCR GPR179 involved in visual processing.

Nature communications
2024

Loss of ON-Pathway Function in Mice Lacking Lrit3 Decreases Recovery From Lens-Induced Myopia.

Investigative ophthalmology &amp; visual science
2024

Differential pathogenetic mechanisms of mutations in helix 2 and helix 6 of rhodopsin.

International journal of biological macromolecules
2024

A novel homozygous nonsense variant in CABP4 causing stationary cone/rod synaptic dysfunction.

Ophthalmic genetics
2024

Anti-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of TRPM1-associated congenital stationary night blindness.

American journal of ophthalmology case reports
2025

Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study.

The British journal of ophthalmology
2024

Cross-species single-cell landscapes identify the pathogenic gene characteristics of inherited retinal diseases.

Frontiers in genetics
2024

Genetic Characterization of 191 Probands with Inherited Retinal Dystrophy by Targeted NGS Analysis.

Genes
2024

Characterizing Retinal Sensitivity and Structure in Congenital Stationary Night Blindness: A Combined Microperimetry and OCT Study.

Investigative ophthalmology &amp; visual science
2024

Nationwide Prevalence of Inherited Retinal Diseases in the Israeli Population.

JAMA ophthalmology
2024

Dark continuous noise from mutant G90D-rhodopsin predominantly underlies congenital stationary night blindness.

Proceedings of the National Academy of Sciences of the United States of America
2025

Diagnosis of Incomplete Congenital Stationary Night Blindness in a 2-year-old boy.

Klinische Monatsblatter fur Augenheilkunde
2024

A Case of Congenital Stationary Night Blindness in a Healthy Female Infant: Emphasis on Electroretinography.

Klinische Monatsblatter fur Augenheilkunde
2024

Congenital Stationary Night Blindness: Structure, Function and Genotype-Phenotype Correlations in a Cohort of 122 Patients.

Ophthalmology. Retina
2024

RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec.

Klinische Monatsblatter fur Augenheilkunde
2024

Aland Island Eye Disease with Retinoschisis in the Clinical Spectrum of CACNA1F-Associated Retinopathy-A Case Report.

International journal of molecular sciences
2024

Clinical and genetic studies for a cohort of patients with congenital stationary night blindness.

Orphanet journal of rare diseases
2024

Compound heterozygous mutations in GRM6 causing complete Schubert-Bornschein type congenital stationary night blindness.

Heliyon
2024

A Drosophila Model Reveals the Potential Role for mtt in Retinal Disease.

International journal of molecular sciences
2024

Unusual OCT findings in a patient with CABP4-associated cone-rod synaptic disorder.

Documenta ophthalmologica. Advances in ophthalmology
2024

CACNA1F-related synaptic dysfunction: challenges diagnosing congenital stationary night blindness presenting without night blindness.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2024

Grk1 Missense Mutations in Type II Oguchi Disease: A Literature Review.

Annals of biomedical research
2024

HIGH MYOPIA IS COMMON IN PATIENTS WITH X-LINKED RETINOPATHIES: Myopic Maculopathy Analysis.

Retina (Philadelphia, Pa.)
2023

Oguchi's disease - Clinical image.

Oman journal of ophthalmology
2023

Fundus Albipunctatus Associated with Biallelic LRAT Gene Mutation: A Case Report with Long-Term Follow-Up.

Journal of clinical medicine
2023

The rod synapse in aging wildtype and Dscaml1 mutant mice.

PloS one
2023

A common cause for nystagmus in different congenital stationary night blindness mouse models.

The Journal of physiology
2023

The Value of Electroretinography in Identifying Candidate Genes for Inherited Retinal Dystrophies: A Diagnostic Guide.

Diagnostics (Basel, Switzerland)
2024

Additional evidence supports GRM6 p.Thr178Met as a cause of congenital stationary night blindness in three horse breeds.

Veterinary ophthalmology
2023

Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections.

International journal of molecular sciences
2023

A retinal origin of nystagmus-a perspective.

Frontiers in ophthalmology
2023

Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort.

International journal of molecular sciences
2023

Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness.

Vision research
2024

Canine and Feline Models of Inherited Retinal Diseases.

Cold Spring Harbor perspectives in medicine
2023

Cav1.4 congenital stationary night blindness is associated with an increased rate of proteasomal degradation.

Frontiers in cell and developmental biology
2023

Mouse all-cone retina models of Cav1.4 synaptopathy.

Frontiers in molecular neuroscience
2023

LRIT3 expression in cone photoreceptors restores post-synaptic bipolar cell signalplex assembly and partial function in Lrit3 -/- mice.

iScience
2023

Characterization of two pathological gating-charge substitutions in Cav1.4 L-type calcium channels.

Channels (Austin, Tex.)
2023

Whale shark rhodopsin adapted to deep-sea lifestyle by a substitution associated with human disease.

Proceedings of the National Academy of Sciences of the United States of America
2023

[Nystagmus in Children - a Survey].

Klinische Monatsblatter fur Augenheilkunde
2023

Shedding light on myopia by studying complete congenital stationary night blindness.

Progress in retinal and eye research
2023

Correlation between the Serum Concentration of Vitamin A and Disease Severity in Patients Carrying p.G90D in RHO, the Most Frequent Gene Associated with Dominant Retinitis Pigmentosa: Implications for Therapy with Vitamin A.

International journal of molecular sciences
2022

Mice Lacking Gpr179 with Complete Congenital Stationary Night Blindness Are a Good Model for Myopia.

International journal of molecular sciences
2023

Upward saccadic intrusions as the presenting feature for incomplete congenital stationary night blindness.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2022

Congenital Stationary Night Blindness: Clinical and Genetic Features.

International journal of molecular sciences
2023

Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series.

Ophthalmic genetics
2023

Genetic analysis and clinical features of three Chinese patients with Oguchi disease.

Documenta ophthalmologica. Advances in ophthalmology
2022

Identification of a novel large multigene deletion and a frameshift indel in PDE6B as the underlying cause of early-onset recessive rod-cone degeneration.

Cold Spring Harbor molecular case studies
2022

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities.

Asian journal of pharmaceutical sciences
2022

Association of Missense Variants in VSX2 With a Peculiar Form of Congenital Stationary Night Blindness Affecting All Bipolar Cells.

JAMA ophthalmology
2023

Multimodal imaging in Schubert-Bornschein congenital stationary night blindness.

Ophthalmic genetics
2022

Assessing the Pathogenicity of In-Frame CACNA1F Indel Variants Using Structural Modeling.

The Journal of molecular diagnostics : JMD
2022

Involvement of transient receptor potential channels in ocular diseases: a narrative review.

Annals of translational medicine
2022

A clinical and electrophysiological case study of a child with a novel frame shift mutation in the CACNA1F and missense variation of RIMS1 genes.

Documenta ophthalmologica. Advances in ophthalmology
2022

Unilateral cataract and congenital stationary night blindness in a child with novel variants in TRPM1.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2022

Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal.

The Journal of biological chemistry
2022

Two novel CACNA1F gene mutations cause two different phenotypes: Aland Eye Disease and incomplete Congenital Stationary Night Blindness.

Experimental eye research
2022

Phenotypes and genotypes underlying paradoxical pupillary reaction in children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2022

Clinical and genetic findings in TRPM1-related congenital stationary night blindness.

Acta ophthalmologica
2022

Mutation analysis reveals novel and known mutations in SAG gene in first two Egyptian families with Oguchi disease.

BMC ophthalmology
2022

Identification of autosomal recessive novel genes and retinal phenotypes in members of the solute carrier (SLC) superfamily.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

SLC24A1-Associated Congenital Stationary Night Blindness in a Woman With an Abnormal Fundus.

JAMA ophthalmology
2022

A novel missense creatine mutant of CaBP4, c.464G>A (p.G155D), associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), reduces the expression of CaBP4.

Translational pediatrics
2022

Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness.

Proceedings of the National Academy of Sciences of the United States of America
2022

Electronegative electroretinogram in the modern multimodal imaging era.

Clinical &amp; experimental ophthalmology
2022

Posterior staphyloma with congenital stationary night blindness.

Journal francais d'ophtalmologie
2022

Genetic Analysis of Consanguineous Pakistani Families with Congenital Stationary Night Blindness.

Ophthalmic research
2021

Comments on 'Whole-genome sequencing identifies missense mutation in GRM6 as the likely cause of congenital stationary night blindness in a Tennessee Walking Horse'.

Equine veterinary journal
2021

Substantial restoration of night vision in adult mice with congenital stationary night blindness.

Molecular therapy. Methods &amp; clinical development
2021

Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes.

Molecular vision
2021

The role of voltage-gated ion channels in visual function and disease in mammalian photoreceptors.

Pflugers Archiv : European journal of physiology
2021

Cav1.4 dysfunction and congenital stationary night blindness type 2.

Pflugers Archiv : European journal of physiology
2021

NYX-related Congenital Stationary Night Blindness in Two Siblings due to Probable Maternal Germline Mosaicism.

Ophthalmic genetics
2022

Two novel compound heterozygous SAG mutations in an Italian patient with Oguchi disease: A genetic and multimodal retinal imaging study.

European journal of ophthalmology
2021

Negative electroretinograms: genetic and acquired causes, diagnostic approaches and physiological insights.

Eye (London, England)
2021

Clinical and Genetic Characteristics of Korean Congenital Stationary Night Blindness Patients.

Genes
2021

Oguchi's disease: two cases and literature review.

The Journal of international medical research
2021

Fundus albipunctatus photoreceptor microstructure revealed using adaptive optics scanning light ophthalmoscopy.

American journal of ophthalmology case reports
2020

Retinal imaging in inherited retinal diseases.

Annals of eye science
2021

A New Mouse Model for Complete Congenital Stationary Night Blindness Due to Gpr179 Deficiency.

International journal of molecular sciences
2021

Complete congenital stationary night blindness associated with a novel NYX variant (p.Asn216Lys) in middle-aged and older adult patients.

Ophthalmic genetics
2021

Panel-based genetic testing for inherited retinal disease screening 176 genes.

Molecular genetics &amp; genomic medicine
2021

Restoration of mGluR6 Localization Following AAV-Mediated Delivery in a Mouse Model of Congenital Stationary Night Blindness.

Investigative ophthalmology &amp; visual science
2021

Structural aspects of rod opsin and their implication in genetic diseases.

Pflugers Archiv : European journal of physiology
2021

Whole-exome sequencing in 168 Korean patients with inherited retinal degeneration.

BMC medical genomics
2021

Congenital stationary night blindness in a patient with mild learning disability due to a compound heterozygous microdeletion of 15q13 and a missense mutation in TRPM1.

Ophthalmic genetics
2021

Stationary and Progressive Phenotypes Caused by the p.G90D Mutation in Rhodopsin Gene.

International journal of molecular sciences
2021

Optic Atrophy and Inner Retinal Thinning in CACNA1F-related Congenital Stationary Night Blindness.

Genes
2021

[Decreased visual acuity as presenting sign of a late case of congenital stationary night blindness: The role of ERG].

Journal francais d'ophtalmologie
2021

A Review of Genetic and Physiological Disease Mechanisms Associated With Cav1 Channels: Implications for Incomplete Congenital Stationary Night Blindness Treatment.

Frontiers in genetics
2021

Function of cone and cone-related pathways in CaV1.4 IT mice.

Scientific reports
2021

A Novel Splice-Site Variant in CACNA1F Causes a Phenotype Synonymous with Åland Island Eye Disease and Incomplete Congenital Stationary Night Blindness.

Genes
2021

Congenital stationary night blindness: an update and review of the disease spectrum in Saudi Arabia.

Acta ophthalmologica
2021

New variants and in silico analyses in GRK1 associated Oguchi disease.

Human mutation
2020

Transgenic Expression of Cacna1f Rescues Vision and Retinal Morphology in a Mouse Model of Congenital Stationary Night Blindness 2A (CSNB2A).

Translational vision science &amp; technology
2020

GUCY2D mutations in retinal guanylyl cyclase 1 provide biochemical reasons for dominant cone-rod dystrophy but not for stationary night blindness.

The Journal of biological chemistry
2021

Novel biallelic TRPM1 variants in an elderly patient with complete congenital stationary night blindness.

Documenta ophthalmologica. Advances in ophthalmology
2020

Functional impact of a congenital stationary night blindness type 2 mutation depends on subunit composition of Cav1.4 Ca2+ channels.

The Journal of biological chemistry
2020

Sensing through Non-Sensing Ocular Ion Channels.

International journal of molecular sciences
2020

A Homozygote Mutation in S-Antigen Visual Arrestin SAG Gene in an Iranian Patient with Oguchi Type One: A Case Report.

Iranian journal of public health
2020

LIM-Homeodomain Transcription Factor LHX4 Is Required for the Differentiation of Retinal Rod Bipolar Cells and OFF-Cone Bipolar Subtypes.

Cell reports
2020

Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant Exonization.

Investigative ophthalmology &amp; visual science
2020

Electronegative Electroretinograms in the United Arab Emirates.

Middle East African journal of ophthalmology
2021

The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies.

Progress in retinal and eye research
2020

Diagnosis of an X-linked type 2 congenital stationary night blindness using electroretinography and CACNA1F sequencing.

Archivos de la Sociedad Espanola de Oftalmologia
2020

Genetics of Equine Ocular Disease.

The Veterinary clinics of North America. Equine practice
2021

Whole-genome sequencing identifies missense mutation in GRM6 as the likely cause of congenital stationary night blindness in a Tennessee Walking Horse.

Equine veterinary journal
2020

Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.

Ophthalmic genetics
2020

Differential adaptations in rod outer segment disc membranes in different models of congenital stationary night blindness.

Biochimica et biophysica acta. Biomembranes
2020

Loss of Function of RIMS2 Causes a Syndromic Congenital Cone-Rod Synaptic Disease with Neurodevelopmental and Pancreatic Involvement.

American journal of human genetics
2020

A Conserved Proline Hinge Mediates Helix Dynamics and Activation of Rhodopsin.

Structure (London, England : 1993)
2020

Using an integrative machine learning approach utilising homology modelling to clinically interpret genetic variants: CACNA1F as an exemplar.

European journal of human genetics : EJHG
2020

Large Animal Models of Inherited Retinal Degenerations: A Review.

Cells
2020

Targeting molecular pathways for the treatment of inherited retinal degeneration.

Neural regeneration research
2020

Congenital Stationary Night Blindness due to Novel TRPM1 Gene Mutations in a Korean Patient.

Korean journal of ophthalmology : KJO
2020

Wide-field true-colour imaging and clinical characterization of a novel GRK1 mutation in Oguchi disease.

Documenta ophthalmologica. Advances in ophthalmology
2020

Ring analysis of multifocal oscillatory potentials (mfOPs) in cCSNB suggests near-normal ON-OFF pathways at the fovea only.

Documenta ophthalmologica. Advances in ophthalmology
2020

Comprehensive Geno- and Phenotyping in a Complex Pedigree Including Four Different Inherited Retinal Dystrophies.

Genes
2020

Retinal degeneration in mice expressing the constitutively active G90D rhodopsin mutant.

Human molecular genetics
2020

A founder RDH5 splice site mutation leads to retinitis punctata albescens in two inbred Pakistani kindreds.

Ophthalmic genetics
2019

Long-term follow-up of retinal function and structure in TRPM1-associated complete congenital stationary night blindness.

Molecular vision
2020

Electroretinographic abnormalities associated with pregabalin: a case report.

Documenta ophthalmologica. Advances in ophthalmology
2020

Nystagmus with pendular low amplitude, high frequency components (PLAHF) in association with retinal disease.

Strabismus
2019

Genetic Deciphering of Early-Onset and Severe Retinal Dystrophy Associated with Sensorineural Hearing Loss.

Advances in experimental medicine and biology
2019

Early onset retinal dystrophies: clinical clues to diagnosis for pediatricians.

Italian journal of pediatrics
2019

Novel frameshift mutation in NYX gene in a Russian family with complete congenital stationary night blindness.

Ophthalmic genetics
2019

Novel homozygous in-frame deletion of GNAT1 gene causes golden appearance of fundus and reduced scotopic ERGs similar to that in Oguchi disease in Japanese family.

Ophthalmic genetics
2019

Pseudodominant inheritance of autosomal recessive congenital stationary night blindness in one family with three co-segregating deleterious GRM6 variants identified by next-generation sequencing.

Molecular genetics &amp; genomic medicine
2019

An Ashkenazi Jewish founder mutation in CACNA1F causes retinal phenotype in both hemizygous males and heterozygous female carriers.

Ophthalmic genetics
2019

A founder deletion in the TRPM1 gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews.

Human genome variation
2019

Extracting the ON and OFF contributions to the full-field photopic flash electroretinogram using summed growth curves.

Experimental eye research
2020

Molecular mechanisms underlying selective synapse formation of vertebrate retinal photoreceptor cells.

Cellular and molecular life sciences : CMLS
2020

Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy.

Documenta ophthalmologica. Advances in ophthalmology
2019

Genome-wide association study and whole-genome sequencing identify a deletion in LRIT3 associated with canine congenital stationary night blindness.

Scientific reports
2019

Nystagmus in patients with congenital stationary night blindness (CSNB) originates from synchronously firing retinal ganglion cells.

PLoS biology
2019

TRPM1 Mutations are the Most Common Cause of Autosomal Recessive Congenital Stationary Night Blindness (CSNB) in the Palestinian and Israeli Populations.

Scientific reports
2019

Presynaptic Expression of LRIT3 Transsynaptically Organizes the Postsynaptic Glutamate Signaling Complex Containing TRPM1.

Cell reports
2019

Genetic Mutation Profiles in Korean Patients with Inherited Retinal Diseases.

Journal of Korean medical science
2019

In vivo electroretinographic differentiation of rod, short-wavelength and long/medium-wavelength cone responses in dogs using silent substitution stimuli.

Experimental eye research
2019

Reading Individual Words Within Sentences in Infantile Nystagmus.

Investigative ophthalmology &amp; visual science
2019

Identification of a novel GRM6 mutation in a previously described consanguineous family with complete congenital stationary night blindness.

Ophthalmic genetics
2019

Disinhibition of intrinsic photosensitive retinal ganglion cells in patients with X-linked congenital stationary night blindness.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2019

[Multimodal diagnostic of CSNB1 with NYX gene mutation].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
2019

A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.

Investigative ophthalmology &amp; visual science
2019

Mizuo-Nakamura phenomenon in an Indian male.

Clinical case reports
2019

Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F-mediated inherited retinal disorders.

Human mutation
2019

Three cases of acute-onset bilateral photophobia.

Japanese journal of ophthalmology
2019

Macular sensitivity in patients with congenital stationary night-blindness.

The British journal of ophthalmology
2019

Photoreceptor degeneration in a new Cacna1f mutant mouse model.

Experimental eye research
2018

Splicing of an automodulatory domain in Cav1.4 Ca2+ channels confers distinct regulation by calmodulin.

The Journal of general physiology
2018

Novel truncating mutation in CACNA1F in a young male patient diagnosed with optic atrophy.

Ophthalmic genetics
2018

Unexpected Genetic Cause in Two Female Siblings with High Myopia and Reduced Visual Acuity.

BioMed research international
2018

Congenital stationary night blindness associated with morning glory disc malformation: a novel hemizygous mutation in CACNA1F.

Ophthalmic genetics
2018

Phenotypic characterization of complete CSNB in the inbred research beagle: how common is CSNB in research and companion dogs?

Documenta ophthalmologica. Advances in ophthalmology
Ver todos os 295 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Cegueira noturna estacionária congênita.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Cegueira noturna estacionária congênita

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Cryo-EM structure of TRPM1 reveals a non-canonical architecture with an inverted transmembrane domain.
    Nature communications· 2026· PMID 41857038mais citado
  2. CryoEM structure of mGlu6 captures receptor activation prior to G protein coupling.
    Nature communications· 2026· PMID 41803130mais citado
  3. EGFLAM Pathogenic Variants and Congenital Stationary Night Blindness.
    JAMA ophthalmology· 2026· PMID 41343198mais citado
  4. A New Gene for Congenital Stationary Night Blindness.
    JAMA ophthalmology· 2026· PMID 41343185mais citado
  5. G-protein activation of the dark-state conformation of the visual G protein-coupled receptor rhodopsin by releasing critical structural constraints.
    Communications biology· 2026· PMID 41775964mais citado
  6. Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variant.
    Doc Ophthalmol· 2026· PMID 41954843recente
  7. Identification and functional validation of a novel disease-causing variant in the noncoding region of NYX.
    Acta Ophthalmol· 2026· PMID 41729106recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:215(Orphanet)
  2. MONDO:0016293(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)
  5. Q18553290(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Cegueira noturna estacionária congênita
Compêndio · Raras BR

Cegueira noturna estacionária congênita

ORPHA:215 · MONDO:0016293
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
H53.6 · Cegueira noturna
CID-11
Ensaios
1 ativos
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0339535
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades